Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm™ (epinephrine) Sublingual Film
Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal Targets Anaphylm 12mg Exceeds Lower Bracket…
Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal Targets Anaphylm 12mg Exceeds Lower Bracket…
Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal Targets Anaphylm 12mg Exceeds Lower Bracket…
Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is…
Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is…
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC),…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC),…
BRISBANE, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage…
BRISBANE, Calif., July 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage…
First purchase orders for sales into Korea, Brazil, and Canada bring Mobilicom’s design wins to…
NEW YORK and PARIS, July 27, 2023 (GLOBE NEWSWIRE) — Neptunus, an international provider of…
NEW YORK and PARIS, July 27, 2023 (GLOBE NEWSWIRE) — Neptunus, an international provider of…
As one of the top and fastest growing OT security vendors, Fortinet is increasing market…
As one of the top and fastest growing OT security vendors, Fortinet is increasing market…
Harmony EDI’s flexibility, enhanced visibility, ease of use, centralized trading partner management and competitive pricing…
Harmony EDI’s flexibility, enhanced visibility, ease of use, centralized trading partner management and competitive pricing…
The youngest generation leads the way with most apps and most usage, but unique preferences…